Last10K.com

Acadia Pharmaceuticals Inc (ACAD) SEC Filing 8-K Material Event for the period ending Tuesday, March 5, 2019

Acadia Pharmaceuticals Inc

HISTORY TOOLS
CIK: 1070494 Ticker: ACAD

View differences made from one to another to evaluate Acadia Pharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acadia Pharmaceuticals Inc.

Continue

Assess how Acadia Pharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acadia Pharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ACAD
CIK: 1070494
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-064601
Submitted to the SEC: Wed Mar 06 2019 6:06:03 AM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Tuesday, March 5, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acad/0001193125-19-064601.htm